Le Lézard
Classified in: Health
Subjects: SVY, CPN, MAT

Up in smoke: it's time to regulate e-cigarettes


A lack of action sees increased cases of acute illness

OTTAWA, Oct. 10, 2019 /CNW Telbec/ - As the vaping crisis continues to spread across Canada, urgent action is needed. With the federal election just two weeks away, all major political parties must commit to immediate and comprehensive measures which regulate e-cigarettes the same way that tobacco is regulated.

In recent months there has been an increase in acute illness linked to vaping. Most concerning is that young people, who deserve to be protected, are most vulnerable to the spread of this vaping epidemic. While some provinces and territories have acted, federal leadership is urgently needed to make sure that regulations are consistent across the country. This must include the use of an interim order, using the powers of the Department of Health Act, that will put vaping products under the same type of regulations that are currently in place for tobacco products.

"The youth vaping crisis has been allowed to escalate because of inadequate regulation and irresponsible marketing practices," says Dr. Andrew Pipe, Chair of the Heart & Stroke Board of Directors. "There is no question that vaping is linked to serious short- and long-term health risks. Canada needs immediate regulations that restrict marketing, a comprehensive ban on flavours and limits on nicotine content."

The results of the lack of regulation are clear. A recent study shows, in just one year, vaping among youth increased by 74% and youth tobacco smoking rates grew by 45%, marking the first time that youth smoking rates in Canada have increased. Other studies have demonstrated that youth who vape are more likely to subsequently begin smoking. E-cigarettes are making it easy for youth to become addicted to nicotine and this increase in vaping could reverse years of hard-fought advances in tobacco control in Canada.

In addition to short- and long-term health harms, limited regulation leads to more and more youth getting addicted to nicotine, which hurts brain development in young people. Advertisements and flavours that appeal to youth are just some of the ways that younger people are becoming addicted to vaping. In order to reverse this alarming trend, the federal government must act immediately. Without action, the health?and lives?of people in Canada, particularly youth, are at stake.

About Heart & Stroke

Life. We don't want you to miss it. That's why Heart & Stroke leads the fight against heart disease and stroke. We must generate the next medical breakthroughs, so people in Canada don't miss out on precious moments. Together, we are working to prevent disease, save lives and promote recovery through research, health promotion and public policy.

SOURCE Heart and Stroke Foundation


These press releases may also interest you

at 09:05
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that a podium talk and multiple abstracts featuring data for the company's NeXT Personal® whole genome-based, tumor-informed assay for ultra-sensitive ctDNA...

at 09:04
Canadian-based Noze, a global leader in the breath-based diagnostic space, announced today it received a new grant from the Bill & Melinda Gates Foundation, bringing the foundation's total grant funding to Noze to $1.8 million. The announcement comes...

at 09:00
Ready. Set. Food! announces the launch of a pioneering clinical study (EASE trial) with ObvioHealth, which will use real-world infant healthcare data to assess how the convenient and early introduction of common food allergens impacts infant...

at 09:00
Product News: ZEISS announces enhanced visualization capabilities with the new ZEISS ARTEVO 850 3D heads-up ophthalmic microscope. Spatial Computing Innovation: ZEISS will demonstrate a digital application for experiencing 3D videos and more on the...

at 09:00
Dr. Aviva Preminger, a leading expert in plastic surgery renowned for her exceptional technique that...

at 09:00
Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse...



News published on and distributed by: